N umerous calculations routinely used for care of the critically ill require knowledge of patients' body weight and height. Actual measurement of weight and height on such patients are not always accomplished (1) (2) (3) . Patients are frequently admitted as emergencies, are not ambulant, or may be unable to communicate, and these factors, in combination, can make accurate estimation or measurements difficult.
Drug dosages and infusion rates in adults are usually based on body weight, as are nutrition prescriptions (4, 5) . Nomograms, such as the Cockcroft-Gault and the Harris-Benedict formulas, as well as intensive care unit (ICU) scoring systems, such as SOFA (Sequential Organ Failure Assessment), rely on knowledge of the patient's weight (6 -8) . Height is also required for calculations of ideal body weight or adjusted body weight (9, 10) , and height or weight is used to calculate and communicate ventilator settings (11) . Both weight and height are required to estimate body surface area and body mass index (9, 12) . Finally, application of many commonly used clinical guidelines and evidence-based practices require the knowledge of height and weight (13) (14) (15) . Thus, accurate estimation or measurement of height and weight of critically ill patients may be important for optimum clinical care.
We, therefore, undertook to investigate the accuracy of visual estimation of weight and height of critically ill patients in our ICU.
PATIENTS AND METHODS
Approval for this study was sought and obtained from the local ethics committee. Written informed consent or assent was received from either the patients or their relatives, respectively. The study was conducted in a 16-bed mixed medical and surgical ICU on two separate days, 3 wks apart.
Study Participants. Patients scheduled to remain in the ICU for the duration of each study day from whom valid consent or relative assent could be obtained were included. Consent or assent was obtained the day before the study to comply with ethics committee requirements. Patients who participated on the first day but remained in the ICU through to the second day were not recruited again, and patients receiving end-of-life care were also excluded. Fourteen patients were estimated by the same 20 assessors who comprised seven senior medical, seven junior medical, and six nursing staff. Patient recruitment and reasons for exclusion from the study are shown in Figure 1 .
Procedures. The weight and height of participating patients were not measured before the study. Assessors were briefed in writing and verbally before the study and were asked to observe each numbered subject for as long as they needed to make an estimate of weight and height and to record this on a sheet in the units of their choice. They were requested not to discuss their observations with other assessors, staff members, or patients, and investigators present throughout the study ensured that observers did not confer within the ICU. Monitoring outside of the ICU was not feasible, and we relied on the professionals involved not to discuss their findings. Assessors' estimates were collected immediately after the observation period by the investigators and were later converted to the International System of Units if necessary. At the conclusion of each study day, the patients were weighed and measured by independent nursing staff, who were otherwise not part of the study and unaware of assessors' estimates, using lifting apparatus with a weighing facility. This consists of a rigid stretcher that lifts the patient completely off the bed surface. The patient's height was marked on the stretcher and then measured with a steel measuring tape. This allowed the height to be measured in as neutral a position as possible, reducing inaccuracies as may be obtained measuring height on a soft bed surface. The Arjo Maximove lifting hoist was used, which conforms to European (Directive 93/42/EEC) and United States (UL 2601) standards for medical devices and can weigh patients of up to 190 kg to a nominal accuracy of 0.1 kg. Accuracy throughout this range was verified using calibration metal weights and demonstrated a maximum difference of Ͻ0.5% across the range of weights encountered in this study.
Statistical Analysis. Descriptive data are presented graphically in box and whisker plots (Figs. 2 and 3 ). Differences between visual estimates and measured values are expressed as percentage of the measured value to maximize biological relevance.
Assessors were assigned post hoc to one of three groups, which comprised seven senior medical staff (consultants and registrars), seven junior medical staff (senior house officers), and six nursing staff. Differences between these groups were analyzed with one-way analysis of variance in combination with Scheffé's technique for multiple comparisons using SPSS for Windows, version 11.0. p Ͻ .05 was taken as the statistical threshold for significance.
RESULTS
Admission diagnoses and individual patient details are listed in Table 1 . The group details of patients and observers are listed in Table 2 . A wide range of body habitus was reflected in both groups.
In absolute terms, weight error ranged from a 34-kg underestimate to a 55-kg overestimate both in a female patient actually weighing 123 kg. Height error ranged from a 16-cm underestimate in a woman measuring 177.5 to a 27-cm overestimate of a woman who measured 151 cm and weighed 102 kg. The percentage estimation errors for individual patients and for individual observers are shown graphically in Figures 2 and 3 . These differences ranged between a 33% underestimate and a 45% overestimate for weight and between a 9% underestimate and an 18% overestimate for height.
Estimates for weight varied considerably from measured weight, with errors of Ն10% evident for 47% of all observations and errors of Ն20% for 19% of all observations. Only three of the 20 observers correctly estimated the weight of all 14 patients to within 25% of the measured values. Estimates of height showed smaller percentage errors from measured values than for weight (Figs. 2 and 3) . The majority of these height estimates were within 10% of the measured values, and in contrast to weight, 18 observers correctly estimated the height of all pa- tients to within 15% of the measured values. There was a trend to overestimate the weight of patients of low body weight and underestimate individuals at the other end of the weight range. A similar but less marked trend was also apparent for height. However, a wide range of estimates was apparent across all measured weights and heights (Fig. 2) .
In a post hoc analysis, we explored whether any group of healthcare professionals might be superior to another because of more direct clinical care or greater experience. Although subject to sample size issues, this analysis failed to show significant differences among groups of senior doctors, junior doctors, and nurses for weight estimates. However differences between groups were apparent for height estimates ( p ϭ .01), with junior doctors overestimating in comparison with senior doctors ( p ϭ .036) and nurses ( p ϭ .031). Although statistically significant, the magnitude of these differences appears unimportant (Fig. 3) .
DISCUSSION
The important findings of this study were that a high proportion of estimates for weight were inaccurate by 20% or more, and individual estimates for weight and height were inaccurate by as much as much as 45% and 18%, respectively. As some ICUs appear not to make measurements (1-3) and rely on estimates of weight and height, these results may serve to guide clinicians and researchers as to the limitations of single estimates. The findings have implications both for clinical practice and research.
Measurement error was small in relation to estimation errors. Measured standing and supine height can differ, but differences are relatively small. Height was measured with a steel rule on supine individuals, and in our unpublished pilot study of 11 surgical patients, the mean difference between supine and standing height was only 0.73 cm (maximum, 3 cm; 1.8%). The weighing device calibration error was also minimal.
Two previous studies have also attempted to address the errors of visual estimation (1, 16) . Neither study reported findings for intensive care patients, and only four observers were used in each study, limiting inferences on observer variability. However, as in this study, each documented substantial estimation errors for height and weight.
Measurement is not a universal practice, and a telephone survey of 20 ICUs in the United Kingdom indicated only two ICUs measured patients' weight, although measurement of height was more commonly performed (1) . Estimation is also used in some European and North American ICUs (2, 3) but may be less prevalent than in the United Kingdom. However, there is little data to quantify current practice confidently.
Although actual body weight and composition will fluctuate during the course of critical illness, it is a true measurement rather than a calculated value, such as lean body mass or ideal body weight. It is actual body weight that is accepted or validated for most calculations and derived values, such as body mass index or body surface area. Actual body weight and ideal or predicted body weight calculated from height-based nomograms are not interchangeable (17) , and this is an important issue for mechanical ventilation of patients (11, 18 -20) . The mean ratio of tidal volumes of actual to predicted body weight produced in this study would have been 1.26 (SD, 0.47), which is close to the value reported by the ARDSnet investigators (19) . However, there was a wide spread of ratios among the individual patients, varying from 0.83 to 2.31. In this last patient, 6 mL·kg Ϫ1 of actual body weight value would be the equivalent of 13.9 mL·kg Ϫ1 of the ARDSnet approach using the height-based nomogram (18) . Use of estimated weights in this study for ventilation produced even more extreme results. By using 6 mL·kg Ϫ1 of actual body weight for two obese patients, the worst estimates would have resulted in tidal volumes of 15.6 and 19.4 mL·kg Ϫ1 of the ARDSnet approach. Use of height estimates produced less divergent results, and the most extreme ratio of 1.56 equates to 9.4 mL·kg Ϫ1 of the ARDSnet approach. The inadvertent use of tidal volumes greatly in excess of those planned could increase the likelihood of iatrogenic lung injury and the risk for mortality of such patients (18, 20) .
Some other clinical practices based on weight and height may also be affected by measurement errors. Important effects might occur with under-or overdosing of drugs that have a narrow therapeutic range. This could predispose to treatment failure or adverse effects as illustrated by the dose-finding study for drotrecogin alfa (activated), which is dosed on a weight basis (21) (22) (23) . Low infusion rates were ineffective, and infusion rates only 25% higher than currently recommended required dose reduction in 50% of these patients in that closely monitored phase II trial (21, 22) . Inaccuracies of cardiac output measurement combined with imprecise height and weight estimates and inaccurate nomograms could lead to substantial final errors in hemodynamic indexes (12, 24) . These sequential systematic and random errors will decrease associations or misclassify individual patients (25) , and patients may then be denied the most appropriate therapeutic option (26) . The combined errors of measurement and estimation may, in part, explain the apparent lack of benefit of these technologies (27) .
Another important reason for measurement is scientific communication (28) , and no study is better than the quality of its data (29) . Many studies of critically ill patients have been unclear as to how body measurement data have been collected, even when reporting important findings that were reliant on this information (15, 20, 30 -34) .
The purpose of clinical experiments or trials is to create a situation in which the only difference between the treatment and control conditions is the intervention of interest (35) . The sensitivity of a clinical experiment, which is the likelihood that an effect if present will be detected, is of fundamental importance to trial design. Experimental error and measurement are two of six factors that determine design sensitivity or power of a study (35, 36) , and "sufficient effort should be spent to ensure that all key data critical to the interpretation of the trial are of high quality" (29) . Imprecision will reduce the power of studies to detect true differences increasing the risk of a type II statistical error or trial sample size requirements. This increases the duration and cost of clinical trials (37) . As this is a source of imprecision that can be pragmatically and inexpensively addressed compared with other design difficulties in critical care research (38 -41) , it is an aspect of research conduct that is worthy of further attention.
CONCLUSIONS
Individual estimates of height and particularly weight are frequently inaccurate. Given their extensive application for diagnostic and therapeutic management, for communication between practitioners, and for scientific research, actual measurements should be preferred to estimates. In some situations, use of estimates could compromise accurate application of effective evidence-based therapies and patient care. In clinical trials in which errors of estimation contribute to a reduction in design sensitivity, estimates will necessitate increased sample size, costs, and duration of that study.
